| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 44.32 | 2835 |
| Intrinsic value (DCF) | 5.42 | 259 |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.